From Princeton Labs to Clinic Shelves: The Rise of Epicutis

Nicole Montgomery talks with Max Stock, founder and CEO of Signum Biosciences and Epicutis, about the science-driven skincare brand built on a patented anti-inflammatory molecule (TSC) developed from Princeton research. They discuss how inflammation and the skin microbiome underlie skin health, Epicutis’s minimalist, high-quality formulations, and the brand’s clinical focus. Max explains why biotech origins give Epicutis an edge in safety, research and formulation, how the line supports aesthetic treatments, and the company’s expansion into Australia with a local office and warehouse to better serve clinics and patients. Epicutis Australia delivers clinically engineered, medical-grade skincare designed to elevate in-clinic results and empower practitioners with science-driven formulations. You can explore their full range at https://epicutis.au/  or connect with them directly via [email protected] or +61 428 986 681 for partnership, training, or stockist enquiries. For a verified overview of their brand, offerings, and business credentials, you can also view their official listing on the Aesthetic Business Masters Directory: https://aestheticbusinessmasters.com.au/directory/epicutis/ . Stay up to date with launches and clinical education by following @epicutis.anz on Instagram: https://www.instagram.com/epicutis.anz/ . Epicutis Australia Premium, medical-grade skincare engineered for clinical results. 🌐 Website: https://epicutis.au/ 📘 ABM Directory Listing: https://aestheticbusinessmasters.com.au/directory/epicutis/ 📧 Email: https://www.instagram.com/epicutis.anz/